MARLBOROUGH, Mass.--(BUSINESS WIRE)--Dec 28, 2021--

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present virtually at the 40 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 1:30 p.m. Eastern Time.

The presentation and Q&A session will be webcast live and may be accessed through a link on the investors section of Hologic’s website at http://investors.hologic.com. The webcast will be available for 30 days following the event.

About Hologic, Inc.

Hologic, Inc. is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.

SOURCE: Hologic, Inc.

View source version on businesswire.com:https://www.businesswire.com/news/home/20211228005012/en/

CONTACT: Paula Izidoro

Senior Investor Relations Specialist

(858) 410-8904

paula.izidoro@hologic.com

KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS

INDUSTRY KEYWORD: RESEARCH SURGERY MEDICAL DEVICES WOMEN INFECTIOUS DISEASES HEALTH CONSUMER GENERAL HEALTH SCIENCE

SOURCE: Hologic, Inc.

Copyright Business Wire 2021.

PUB: 12/28/2021 08:15 AM/DISC: 12/28/2021 08:17 AM

http://www.businesswire.com/news/home/20211228005012/en